Literature DB >> 27618931

Tumor infiltrating lymphocytes in lung cancer: a new prognostic parameter.

Kobe Reynders1, Dirk De Ruysscher2.   

Abstract

Entities:  

Year:  2016        PMID： 27618931      PMCID： PMC4999748          DOI： 10.21037/jtd.2016.07.75

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  19 in total

1.  A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years.

Authors:  Bettina S Nedergaard; Morten Ladekarl; Jens Randel Nyengaard; Karsten Nielsen
Journal:  Gynecol Oncol       Date:  2007-10-22       Impact factor: 5.482

2.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

3.  Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells.

Authors:  Timothy M Illidge; Jamie Honeychurch; Simon J Dovedi; Grazyna Lipowska-Bhalla; Stephen A Beers; Eleanor J Cheadle; Lijun Mu; Martin J Glennie
Journal:  Cancer Immunol Res       Date:  2016-05-30       Impact factor: 11.151

4.  Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.

Authors:  Agapi Kataki; Philippe Scheid; Maud Piet; Beatrice Marie; Nadine Martinet; Yves Martinet; Jean-Michel Vignaud
Journal:  J Lab Clin Med       Date:  2002-11

5.  Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.

Authors:  Jérôme Galon; Anne Costes; Fatima Sanchez-Cabo; Amos Kirilovsky; Bernhard Mlecnik; Christine Lagorce-Pagès; Marie Tosolini; Matthieu Camus; Anne Berger; Philippe Wind; Franck Zinzindohoué; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès
Journal:  Science       Date:  2006-09-29       Impact factor: 47.728

6.  Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.

Authors:  Rebecca P Petersen; Michael J Campa; Justin Sperlazza; Debbi Conlon; Mary-Beth Joshi; David H Harpole; Edward F Patz
Journal:  Cancer       Date:  2006-12-15       Impact factor: 6.860

7.  Density of tumor-infiltrating lymphocytes correlates with disease recurrence and survival in patients with large non-small-cell lung cancer tumors.

Authors:  Arman Kilic; Rodney J Landreneau; James D Luketich; Arjun Pennathur; Matthew J Schuchert
Journal:  J Surg Res       Date:  2009-09-23       Impact factor: 2.192

8.  CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers.

Authors:  Osamu Wakabayashi; Koichi Yamazaki; Satoshi Oizumi; Fumihiro Hommura; Ichiro Kinoshita; Shigeaki Ogura; Hirotoshi Dosaka-Akita; Masaharu Nishimura
Journal:  Cancer Sci       Date:  2003-11       Impact factor: 6.716

9.  Objective measurement and clinical significance of TILs in non-small cell lung cancer.

Authors:  Kurt A Schalper; Jason Brown; Daniel Carvajal-Hausdorf; Joseph McLaughlin; Vamsidhar Velcheti; Konstantinos N Syrigos; Roy S Herbst; David L Rimm
Journal:  J Natl Cancer Inst       Date:  2015-02-03       Impact factor: 11.816

10.  Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma.

Authors:  K Hiraoka; M Miyamoto; Y Cho; M Suzuoki; T Oshikiri; Y Nakakubo; T Itoh; T Ohbuchi; S Kondo; H Katoh
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640
View more
  11 in total

1.  89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer.

Authors:  Christopher G England; Dawei Jiang; Emily B Ehlerding; Brian T Rekoske; Paul A Ellison; Reinier Hernandez; Todd E Barnhart; Douglas G McNeel; Peng Huang; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-19       Impact factor: 9.236

2.  Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity.

Authors:  Sanjib Chaudhary; Koelina Ganguly; Sakthivel Muniyan; Ramesh Pothuraju; Zafar Sayed; Dwight T Jones; Surinder K Batra; Muzafar A Macha
Journal:  J Natl Cancer Inst       Date:  2019-03-01       Impact factor: 13.506

3.  Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma.

Authors:  Kui Cao; Mingdong Liu; Keru Ma; Xiangyu Jiang; Jianqun Ma; Jinhong Zhu
Journal:  Cancer Immunol Immunother       Date:  2021-10-15       Impact factor: 6.968

4.  Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer.

Authors:  Radu Pirlog; Paul Chiroi; Ioana Rusu; Ancuta Maria Jurj; Liviuta Budisan; Cecilia Pop-Bica; Cornelia Braicu; Doinita Crisan; Jean-Christophe Sabourin; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

5.  Patterns of immune infiltration in lung adenocarcinoma revealed a prognosis-associated microRNA-mast cells network.

Authors:  Chunlin Wang; Xi Tang; Jiaojian Wang; Yanhua Xu
Journal:  Hum Cell       Date:  2019-12-20       Impact factor: 4.174

6.  Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer.

Authors:  Dan Chen; Huanhuan Sha; Tianmu Hu; Shuchen Dong; Junying Zhang; Siwen Liu; Haixia Cao; Rong Ma; Yang Wu; Changwen Jing; Zhuo Wang; Jianzhong Wu; Jifeng Feng
Journal:  Cell Death Dis       Date:  2018-03-06       Impact factor: 8.469

7.  Artificial intelligence-based analysis for immunohistochemistry staining of immune checkpoints to predict resected non-small cell lung cancer survival and relapse.

Authors:  Haoyue Guo; Li Diao; Xiaofeng Zhou; Jie-Neng Chen; Yue Zhou; Qiyu Fang; Yayi He; Rafal Dziadziuszko; Caicun Zhou; Fred R Hirsch
Journal:  Transl Lung Cancer Res       Date:  2021-06

8.  Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer.

Authors:  Mei-Ren Pan; Cheng-Che Wu; Jung-Yu Kan; Qiao-Lin Li; Shu-Jyuan Chang; Chun-Chieh Wu; Chung-Liang Li; Fu Ou-Yang; Ming-Feng Hou; Hon-Kan Yip; Chi-Wen Luo
Journal:  Cancers (Basel)       Date:  2019-12-30       Impact factor: 6.639

9.  Prognostic value of the common tumour-infiltrating lymphocyte subtypes for patients with non-small cell lung cancer: A meta-analysis.

Authors:  Benchao Chen; Heng Li; Chao Liu; Xudong Xiang; Shuting Wang; Anhao Wu; Yan Shen; Gaofeng Li
Journal:  PLoS One       Date:  2020-11-10       Impact factor: 3.240

10.  CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer.

Authors:  Andrea Moreno-Manuel; Eloisa Jantus-Lewintre; Ines Simões; Fernando Aranda; Silvia Calabuig-Fariñas; Esther Carreras; Sheila Zúñiga; Yvonne Saenger; Rafael Rosell; Carlos Camps; Francisco Lozano; Rafael Sirera
Journal:  Transl Lung Cancer Res       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.